Moore Timothy L.
Chief Technical Officer at ALLO; EVP, Technical Operations at Kite Pharma, Inc.
- Sold, on record
- $3.4M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Feb 3, 2025
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ALLOAllogene Therapeutics, Inc.Chief Technical Officer
- Kite Pharma, Inc.EVP, Technical Operations
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Kite Pharma, Inc.29,739 shares
- ALLO14,746 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Kite Pharma, Inc.Plan not statedAug 1, 2017 2017
Sold 12,000 shares at $107.69 ($1.3M)
Moore Timothy L., EVP, Technical Operations
Sold 19.5% of holdings ($6.6M position)49,400 shares leftFirst sale on recordFiling
- 2 Form 4 sale Kite Pharma, Inc.Plan not statedAug 3, 2017 +2 days
Sold 6,000 shares at $110.06 ($660k)
Moore Timothy L., EVP, Technical Operations
Sold 10.8% of holdings ($6.1M position)49,400 shares leftFiling
- 3 Form 4 sale Kite Pharma, Inc.Plan not statedSep 25, 2017 +53 days
Sold 11,739 shares at $118.01 ($1.4M)
Moore Timothy L., EVP, Technical Operations
Sold 20.5% of holdings ($6.8M position)45,661 shares leftFirst sale on recordFiling
- 4 Form 144 notice ALLONoticeApr 22, 2024 +2401 days
Filed to sell 17,360 shares ($60k)
Moore Timothy L., Officer
No 10b5-1 planFirst sale on recordFiling
- 5 Form 4 sale ALLONo planFeb 3, 2025 +287 days
Sold 14,746 shares at $1.71 ($25k)
Moore Timothy L., Chief Technical Officer
No 10b5-1 planSold 5.6% of holdings ($454k position)250,713 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Feb 5, 2025 | ALLO | Chief Technical Officer | Form 4 sale | 14,746 | $25k | 5.6% | No plan | SEC |
| Apr 22, 2024 | Apr 22, 2024 | ALLO | Officer | Form 144 notice | 17,360 | $60k | Notice | SEC | |
| Sep 25, 2017 | Sep 27, 2017 | Kite Pharma, Inc. | EVP, Technical Operations | Form 4 sale | 11,739 | $1.4M | 20.5% | Plan not stated | SEC |
| Aug 3, 2017 | Aug 4, 2017 | Kite Pharma, Inc. | EVP, Technical Operations | Form 4 sale | 6,000 | $660k | 10.8% | Plan not stated | SEC |
| Aug 1, 2017 | Aug 3, 2017 | Kite Pharma, Inc. | EVP, Technical Operations | Form 4 sale | 12,000 | $1.3M | 19.5% | Plan not stated | SEC |